Medical Review Institute of America (“MRIoA” or the “Company”), a leading provider of outsourced utilization management and clinical review solutions to payers, announced a strategic investment from Parthenon Capital (“Parthenon”), a growth-oriented private equity firm. As part of the transaction, MRIoA management and Summit Partners, an investor in MRIoA since 2017, will both retain significant positions in the business. Dan Killeen, a Partner at Parthenon, said, “MRIoA plays a critical role in enabling payer organizations to ensure members receive timely access to the care they need.”
Read the full article: Parthenon Capital Announces Strategic Growth Investment in Medical Review Institute of America //
Source: https://www.businesswire.com/news/home/20240708398015/en/Parthenon-Capital-Announces-Strategic-Growth-Investment-in-Medical-Review-Institute-of-America